Company Name:  Achillion Pharmaceuticals Inc  Ticker Symbol:  ACHN  CIK Number:  0001070336  WWW Address:  http://www.achillion.com 
CEO:  Milind S. Deshpande,PhD  No. of Employees:  81 
Common Issue Type:  CS  Business Description:  Achillion Pharmaceuticals, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative treatments for infectious diseases.

  Industry Information:  DRUGS  Biotechnology [more like this] 
 Price  Day Change  Bid  Ask  Open  High  Low  Volume  4.01  0.01  4.0  4.01  3.96  4.02  3.80  543338 
Market Cap (mil)  Shares Outstanding (mil)  Beta  EPS  DPS  P/E  Yield  52WksRange 
553.0  137.9  0.00  0.62  0.00  0.0  0.0  5.66  2.58 
 KEY FIGURES (Latest Twelve Months  LTM)  Yesterday's Close  3.99  $  PE Ratio  LTM  0.0  
Market Capitalisation  553.0  mil 
Latest Shares Outstanding  137.9  mil 
Earnings pS (EPS)  0.62  $ 
Dividend pS (DPS)  0.00  ¢ 
Dividend Yield  0.0  % 
Dividend Payout Ratio   % 
Revenue per Employee   $ 
Effective Tax Rate  0.0  % 
Float  115.8  mil 
Float as % of Shares Outstanding  0.8  % 
Foreign Sales   mil 
Domestic Sales   mil 
Selling, General & Adm/tive (SG&A) as % of Revenue  0.00  % 
Research & Devlopment (R&D) as % of Revenue  0.00  % 
Gross Profit Margin  0.0  % 
EBITDA Margin  0.0  % 
PreTax Profit Margin  0.0  % 
Assets Turnover  0.0  % 
Return on Assets (ROA)  22.7  % 
Return on Equity (ROE)  23.5  % 
Return on Capital Invested (ROCI)  24.7  % 
Current Ratio  23.6  
Leverage Ratio (Assets/Equity)  1.0  
Interest Cover  1703.7  
Total Debt/Equity (Gearing Ratio)  0.00  
LT Debt/Total Capital  0.0  % 
Working Capital pS  2.11  $ 
Cash pS  0.00  $ 
BookValue pS  2.35  $ 
Tangible BookValue pS  2.35  $ 
Cash Flow pS  0.43  $ 
Free Cash Flow pS  0.44  $ 

KEY FIGURES (LTM): Price info 
Price/Book Ratio  1.49  
Price/Tangible Book Ratio  0.00  
Price/Cash Flow   
Price/Free Cash Flow   
P/E as % of Industry Group  0.0  % 
P/E as % of Sector Segment  0.0  % 
  Balance Sheet (at a glance) in Millions 
   DIVIDEND INFO  Type of Payment   
Dividend Rate  0.00 
Current Dividend Yield  0.0 
5Y Average Dividend Yield  0.0 
Payout Ratio  0.0 
5Y Average Payout Ratio  0.0 
 
 
 
 
 
  Share price performance previous 3 years 
   Share price performance intraday 
    PRICE/VOLUME  High  Low  Close  % Price Chg  % Price Chg vs. Mkt.  Avg. Daily Vol  Total Vol 
1 Week        7.0  6  2,174,744  5,445,411 
4 Weeks  4.34  2.70  3.00  29.0  29  2,159,142  45,341,995 
13 Weeks  4.34  2.58  2.93  32.1  31  2,008,362  124,518,477 
26 Weeks  4.82  2.58  4.11  5.8  14  2,001,424  252,179,488 
52 Weeks  5.66  2.58  3.86  0.3  15  1,796,692  452,766,551 
YTD  4.34  2.58    25.2  25  1,995,758  109,766,702 
Moving Average  5Days  10Days  10Weeks  30Weeks  200Days  Beta (60Mnth)  Beta (36Mnth) 
 3.94  4.04  3.23  3.62  3.84  0.00  0.00 
  GROWTH RATES  5Year Growh  R² of 5Year Growth  3Year Growth 
Revenue   0.0  0.00 
Income   0.0  
Dividend   0.0  
Capital Spending   NA  
R&D  11.48  NA  28.43 
Normalized Inc.  0.00  NA  0.00 
  CHANGES  YTD vs. Last YTD  Curr Qtr vs. Qtr 1Yr ago  Annual vs. Last Annual 
Revenue %  100.0  100.0  955.5 
Earnings %  0.0  0.0  0.0 
EPS %  0.0  0.0  0.0 
EPS $  0.01  0.01  0.05 
  SOLVENCY RATIOS  SHORTTERM SOLVENCY RATIOS (LIQUIDITY) 
Net Working Capital Ratio  86.21 
Current Ratio  23.6 
Quick Ratio (Acid Test)  23.4 
Liquidity Ratio (Cash)  26.67 
Receivables Turnover  0.0 
Average Collection Period  
Working Capital/Equity  89.7 
Working Capital pS  2.11 
CashFlow pS  0.43 
Free CashFlow pS  0.44 
FINANCIAL STRUCTURE RATIOS 
Altman's ZScore Ratio  21.58 
Financial Leverage Ratio (Assets/Equity)  0.0 
Debt Ratio  0.1 
Total Debt/Equity (Gearing Ratio)  0.00 
LT Debt/Equity  0.00 
LT Debt/Capital Invested  0.1 
LT Debt/Total Liabilities  43.5 
Interest Cover  1703.7 
Interest/Capital Invested  0.02 
  VALUATION RATIOS  MULTIPLES 
PQ Ratio  0.00 
Tobin's Q Ratio  1.41 
Current P/E Ratio  LTM  0.00 
Enterprise Value (EV)/EBITDA  1.71 
Enterprise Value (EV)/Free Cash Flow  2.18 
Dividend Yield  0.0 
Price/Tangible Book Ratio  LTM  0.00 
Price/Book Ratio  LTM  1.49 
Price/Cash Flow Ratio  
Price/Free Cash Flow Ratio  LTM  
Price/Sales Ratio  0.00 
P/E Ratio (1 month ago)  LTM  0.0 
P/E Ratio (26 weeks ago)  LTM  0.0 
P/E Ratio (52 weeks ago)  LTM  0.0 
5Y High P/E Ratio  0.0 
5Y Low P/E Ratio  0.0 
5Y Average P/E Ratio  0.0 
Current P/E Ratio as % of 5Y Average P/E  
P/E as % of Industry Group  0.0 
P/E as % of Sector Segment  0.0 
Current 12 Month Normalized P/E Ratio  LTM  0.0 
PER SHARE FIGURES 
LT Debt pS  0.00 
Current Liabilities pS  0.11 
Tangible Book Value pS  LTM  2.35 
Book Value pS  LTM  2.35 
Capital Invested pS  2.36 
Cash pS  LTM  0.00 
Cash Flow pS  LTM  0.43 
Free Cash Flow pS  LTM  0.44 
Earnings pS (EPS)  0.62 
  OPERATING RATIOS  PROFITABILITY RATIOS 
Free Cash Flow Margin  0.00 
Free Cash Flow Margin 5YEAR AVG  89.41 
Net Profit Margin  0.0 
Net Profit Margin  5YEAR AVRG.  
Equity Productivity  0.00 
Return on Equity (ROE)  0.2 
Return on Equity (ROE)  5YEAR AVRG.  0.3 
Capital Invested Productivity  0.00 
Return on Capital Invested (ROCI)  0.3 
Return on Capital Invested (ROCI)  5YEAR AVRG.  0.3 
Assets Productivity  0.00 
Return on Assets (ROA)  0.2 
Return on Assets (ROA)  5YEAR AVRG.  0.3 
Gross Profit Margin  0.0 
Gross Profit Margin  5YEAR AVRG.  
EBITDA Margin  LTM  0.0 
EBIT Margin  LTM  0.0 
PreTax Profit Margin  0.0 
PreTax Profit Margin  5YEAR AVRG.  
Effective Tax Rate  0.0 
Effective Tax Rate  5YEAR AVRG.  0.0 
EFFICIENCY RATIOS 
Cash Conversion Cycle  
Revenue per Employee  
Net Income per Employee  
Average Collection Period  
Receivables Turnover  0.0 
Day's Inventory Turnover Ratio  
Inventory Turnover  0.0 
Inventory/Sales  0.0 
Accounts Payble/Sales  0.00 
Assets/Revenue  0.00 
Net Working Capital Turnover  0.00 
Fixed Assets Turnover  0.00 
Total Assets Turnover  0.0 
Revenue per $ Cash  0.00 
Revenue per $ Plant  0.00 
Revenue per $ Common Equity  0.00 
Revenue per $ Capital Invested  0.00 
Selling, General & Adm/tive (SG&A) as % of Revenue  0.0 
SG&A Expense as % of Revenue  5YEAR AVRG.  0.0 
Research & Devlopment (R&D) as % of Revenue  0.0 
R&D Expense as % of Revenue  5YEAR AVRG.  0.0 

      